Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Chimeric Therapeutics Ltd. ( (AU:CHM) ) has shared an announcement.
Chimeric Therapeutics Ltd. has announced an Extraordinary General Meeting (EGM) scheduled for July 23, 2025, to be held both physically in Victoria and virtually online. This meeting provides an opportunity for shareholders to participate and vote on company matters, reflecting the company’s commitment to engaging with its stakeholders and ensuring their involvement in decision-making processes.
More about Chimeric Therapeutics Ltd.
Chimeric Therapeutics Ltd. operates in the biotechnology industry, focusing on the development of innovative cell therapies for cancer treatment.
Technical Sentiment Signal: Sell
Current Market Cap: A$8.06M
For a thorough assessment of CHM stock, go to TipRanks’ Stock Analysis page.